There have been reports of muscle pain, tenderness or weakness, particularly in combination antiretroviral therapy including protease inhibitors and nucleoside analogues.
39 On registreeritud lihasvalu, - hellust või – nõrkust, eriti proteaasi inhibiitoreid ja nukleosiidi analooge sisaldava kombineeritud retroviirusevastase ravi korral.